Robert Wasserman
Stock Analyst at Benchmark
(2.28)
# 2,759
Out of 4,858 analysts
122
Total ratings
43.52%
Success rate
-3.51%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Reiterates: Buy | $75 | $51.54 | +45.52% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $6.95 | +115.83% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $1.62 | +270.37% | 9 | May 12, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $120.03 | +16.64% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $25.24 | +38.67% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $0.60 | +399.67% | 6 | Apr 1, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $3.23 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $53.85 | +39.28% | 8 | Feb 20, 2025 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $135 | $115.39 | +16.99% | 10 | Dec 23, 2024 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $23.72 | +26.48% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $1.16 | +589.66% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $3.80 | +31.75% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $6.67 | +79.91% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.36 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $132.00 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.58 | +1,972.54% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $39.32 | +14.45% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $4.67 | -14.34% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.40 | +900.00% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $2.10 | +3,471.43% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $204.72 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $415.15 | +39.71% | 1 | Jul 16, 2021 |
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $51.54
Upside: +45.52%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $6.95
Upside: +115.83%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.62
Upside: +270.37%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $120.03
Upside: +16.64%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $25.24
Upside: +38.67%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $0.60
Upside: +399.67%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.23
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $53.85
Upside: +39.28%
Ligand Pharmaceuticals
Dec 23, 2024
Reiterates: Buy
Price Target: $135
Current: $115.39
Upside: +16.99%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $23.72
Upside: +26.48%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $3.80
Upside: +31.75%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $6.67
Upside: +79.91%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.36
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $132.00
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.58
Upside: +1,972.54%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $39.32
Upside: +14.45%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $4.67
Upside: -14.34%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.40
Upside: +900.00%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $2.10
Upside: +3,471.43%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $204.72
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $415.15
Upside: +39.71%